Sunitinib and salts thereof and their polymorphs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8618309
APP PUB NO 20110118477A1
SERIAL NO

13055609

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA PHARMACEUTICALS USA INC1090 HORSHAM ROAD NORTH WALES PA 19454-1090

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Canavesi, Augusto Locate Varesino (CO), IT 23 19
Gavenda, Ales Ostrava-Lhotka, CZ 15 68
Jegorov, Alexandr Dobra Voda, CZ 56 195
Scarpitta, Francesca Ivrea (TO), IT 17 27
Vraspir, Pavel Rymarov, CZ 12 40

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00